Direct-acting antiviral therapies for hepatitis C infection: global registration, reimbursement, and restrictions

Alison Marshall*, Alex R. Willing, Abe Kairouz, Evan B Cunningham, Matt Hickman, Peter T Vickerman

*Corresponding author for this work

Research output: Contribution to journalArticle (Academic Journal)peer-review

3 Citations (Scopus)
1 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Direct-acting antiviral therapies for hepatitis C infection: global registration, reimbursement, and restrictions'. Together they form a unique fingerprint.

Medicine and Dentistry